HK1218861A1 - 包含異煙肼顆粒和利福噴汀顆粒的呈可分散的片劑形式的抗結核病的穩定的藥物組合物及其製備方法 - Google Patents

包含異煙肼顆粒和利福噴汀顆粒的呈可分散的片劑形式的抗結核病的穩定的藥物組合物及其製備方法

Info

Publication number
HK1218861A1
HK1218861A1 HK16106876.8A HK16106876A HK1218861A1 HK 1218861 A1 HK1218861 A1 HK 1218861A1 HK 16106876 A HK16106876 A HK 16106876A HK 1218861 A1 HK1218861 A1 HK 1218861A1
Authority
HK
Hong Kong
Prior art keywords
granules
rifapentine
isoniazid
preparation
pharmaceutical composition
Prior art date
Application number
HK16106876.8A
Other languages
English (en)
Inventor
Prajapati Dilip
Prasad Kum
Khullar Praveen
Kumar Ramesh
Kumar Shakti
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=51211798&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1218861(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of HK1218861A1 publication Critical patent/HK1218861A1/zh

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05Phenols
    • A61K31/06Phenols the aromatic ring being substituted by nitro groups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4409Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 4, e.g. isoniazid, iproniazid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2095Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • A61P31/06Antibacterial agents for tuberculosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
HK16106876.8A 2013-07-26 2016-06-15 包含異煙肼顆粒和利福噴汀顆粒的呈可分散的片劑形式的抗結核病的穩定的藥物組合物及其製備方法 HK1218861A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN3342CH2013 2013-07-26
PCT/EP2014/065762 WO2015011162A1 (en) 2013-07-26 2014-07-22 Anti-tuberculosis stable pharmaceutical composition in a form of a dispersible tablet comprising granules of isoniazid and granules of rifapentine and its process of preparation

Publications (1)

Publication Number Publication Date
HK1218861A1 true HK1218861A1 (zh) 2017-03-17

Family

ID=51211798

Family Applications (1)

Application Number Title Priority Date Filing Date
HK16106876.8A HK1218861A1 (zh) 2013-07-26 2016-06-15 包含異煙肼顆粒和利福噴汀顆粒的呈可分散的片劑形式的抗結核病的穩定的藥物組合物及其製備方法

Country Status (18)

Country Link
US (1) US9814680B2 (zh)
EP (1) EP3024444A1 (zh)
JP (2) JP2016539110A (zh)
CN (1) CN105407876B (zh)
AU (1) AU2014295099B2 (zh)
CA (1) CA2918528A1 (zh)
CL (1) CL2016000183A1 (zh)
HK (1) HK1218861A1 (zh)
IL (1) IL243369A0 (zh)
MX (1) MX2016001155A (zh)
PE (1) PE20160245A1 (zh)
PH (1) PH12016500119A1 (zh)
RU (1) RU2694056C2 (zh)
SA (1) SA516370446B1 (zh)
SG (2) SG11201510732VA (zh)
TW (1) TWI630911B (zh)
WO (1) WO2015011162A1 (zh)
ZA (1) ZA201600110B (zh)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2672879C2 (ru) 2013-07-26 2018-11-20 Санофи Противотуберкулезная композиция, содержащая рифампицин, изониазид, этамбутол и пиразинамид, и способ ее получения
MX2023005395A (es) * 2020-11-09 2023-05-19 Realta Life Sciences Inc Formulaciones de peptidos y metodos de uso.
CN112730657A (zh) * 2020-12-18 2021-04-30 卓和药业集团有限公司 利福喷丁含量的分析检测方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1217912A (zh) * 1997-11-26 1999-06-02 岑冠新 复方利福喷丁制剂及制备方法
TR200200966T1 (tr) * 2000-08-09 2002-09-23 Panacea Biotec Limited Tüberkülöz ilaçlarının yeni farmasötik terkipleri ve hazırlanma prosesleri
JP4446463B2 (ja) * 2000-10-16 2010-04-07 第一三共株式会社 口腔内速崩壊性医薬組成物およびその製造方法
BR0116994A (pt) 2001-04-27 2004-03-02 Lupin Ltd Um processo aperfeiçoado para a preparação de uma composição que abrange uma combinação de dose fixa (fdc) de quatro drogas antituberculose
US20050059719A1 (en) 2003-09-16 2005-03-17 Badawy Sherif Ibrahim Farag Solid dosage formulation containing a Factor Xa inhibitor and method
TW201434467A (zh) 2005-10-05 2014-09-16 Otsuka Pharma Co Ltd 抗結核治療藥物及含彼之套組
JP5105818B2 (ja) * 2005-10-05 2012-12-26 大塚製薬株式会社 医薬組成物
JPWO2007043452A1 (ja) * 2005-10-12 2009-04-16 パイオニア株式会社 車載撮影装置及び車載カメラの撮影可動範囲測定方法
CN1989966B (zh) 2005-12-30 2011-06-08 重庆华邦制药股份有限公司 含利福平和异烟肼的药物组合物
CN1857280A (zh) * 2006-04-11 2006-11-08 济南帅华医药科技有限公司 一种复方抗结核药物缓释制剂
EP2184983A1 (en) * 2007-08-06 2010-05-19 Insys Therapeutics Inc. Oral cannabinoid liquid formulations and methods of treatment
KR101197277B1 (ko) * 2009-02-05 2012-11-05 (주) 벡스코아 경구용 결핵의 치료용 또는 예방용 고형 제형
AP2012006119A0 (en) 2009-07-31 2012-02-29 Cadila Pharmaceuticals Ltd Pharmaceutical composition of isoniazid.
US20130129791A1 (en) * 2010-05-04 2013-05-23 Mahmut Bilgic Preparations of effervescent formulations comprising second and third generation cephalosporin and uses thereof
WO2012013756A2 (fr) 2010-07-28 2012-02-02 Laboratoires Pharma 5 Procédé de préparation de comprimés contenant en association la rifampicine, l'isoniazide, la pyrazinamide, et éventuellement l'ethambutol
US8470365B2 (en) * 2010-07-29 2013-06-25 Taiwan Biotech Co., Ltd. Process for preparation of anti-tubercular combination and pharmaceutical composition prepared therefrom
RU2672879C2 (ru) 2013-07-26 2018-11-20 Санофи Противотуберкулезная композиция, содержащая рифампицин, изониазид, этамбутол и пиразинамид, и способ ее получения
SG11201510730UA (en) 2013-07-26 2016-01-28 Sanofi Sa Anti-tuberculosis stable pharmaceutical composition in a form of a coated tablet comprising granules of isoniazid and granules of rifapentine and its process of preparation

Also Published As

Publication number Publication date
SG10201803996WA (en) 2018-06-28
TWI630911B (zh) 2018-08-01
JP2016539110A (ja) 2016-12-15
CN105407876A (zh) 2016-03-16
AU2014295099B2 (en) 2019-07-11
MX2016001155A (es) 2016-04-29
AU2014295099A1 (en) 2016-02-11
CN105407876B (zh) 2019-08-30
ZA201600110B (en) 2017-04-26
EP3024444A1 (en) 2016-06-01
US20160184231A1 (en) 2016-06-30
RU2016106328A (ru) 2017-08-31
CA2918528A1 (en) 2015-01-29
WO2015011162A1 (en) 2015-01-29
SG11201510732VA (en) 2016-01-28
PH12016500119A1 (en) 2016-04-25
JP6476331B2 (ja) 2019-02-27
IL243369A0 (en) 2016-02-29
SA516370446B1 (ar) 2018-09-13
RU2694056C2 (ru) 2019-07-09
US9814680B2 (en) 2017-11-14
JP2018123147A (ja) 2018-08-09
CL2016000183A1 (es) 2016-07-01
TW201601723A (zh) 2016-01-16
PE20160245A1 (es) 2016-05-10

Similar Documents

Publication Publication Date Title
IL245345A0 (en) History of pyridine, pyrimidine, pyrazine and pyridazine, their preparation and pharmaceutical preparations containing them
EP2815746A4 (en) SAPONIN NANOMIZELES, MANUFACTURING METHOD, APPLICATION THEREOF AND PHARMACEUTICAL COMPOSITION THEREOF
IL271352B (en) A pharmaceutical preparation containing a derivative of glutarimide and its use in the treatment of eosinophilic diseases
HK1212980A1 (zh) 吡啶酮類衍生物、其製備方法及其在醫藥上的應用
IL240291B (en) History of pyridazinone and pharmaceutical preparations containing them
HK1221649A1 (zh) 包含乙酰水楊酸和氯吡格雷的藥物片劑
IL240496B (en) History of pyridine, process for their preparation, pharmaceutical preparations containing them and their use in medicine
EP2978423A4 (en) STABLE NANO COMPOSITION WITH DOXORUBICIN, PROCESS FOR THE PREPARATION THEREOF, THE USE THEREOF AND PHARMACEUTICAL COMPOSITIONS THEREWITH
IL243227A0 (en) History of diaminocyclopentane carboxamide, their preparation and pharmaceutical preparations containing them
HK1214519A1 (zh) 雙用途硫酸鹽口服藥物組合物片劑及其使用方法
PT3102187T (pt) Composições farmacêuticas estáveis contendo sitagliptina sob a forma de comprimidos de libertação imediata
EP2978428A4 (en) STABLE NANO COMPOSITION WITH EPIRUBICIN, PROCESS FOR THE PRODUCTION THEREOF, THE USE THEREOF AND PHARMACEUTICAL COMPOSITIONS THEREWITH
HK1218861A1 (zh) 包含異煙肼顆粒和利福噴汀顆粒的呈可分散的片劑形式的抗結核病的穩定的藥物組合物及其製備方法
HK1245155A1 (zh) 製備去氧腎上腺素樹脂酸鹽顆粒的方法;去氧腎上腺素樹脂酸鹽顆粒;以及去氧腎上腺素樹脂酸鹽顆粒在藥物製劑中的用途
HK1218862A1 (zh) 包含異煙肼顆粒和利福噴汀顆粒的呈包衣片劑形式的抗結核病的穩定的藥物組合物及其製備方法
IL245415A0 (en) A process for the preparation of methylphenidate and its pharmaceutical salts
GB201307082D0 (en) Pharmaceutical composition comprising 15-HETrE and methods of using the same
MX2016006742A (es) Composicion farmaceutica.
HRP20180781T1 (hr) Farmaceutski pripravak koji sadržava lidipidipin i proces pripreme
ZA201506656B (en) Pharmaceutical compositions of donepezil having specific in vitro dissolution profile or pharmacokinetics parameters
ZA201506665B (en) Pharmaceutical compositions of donepezil having specific in vitro dissolution profile or pharmacokinetics parameters
TH1601000296A (th) องค์ประกอบทางเภสัชกรรมที่เสถียรซึ่งต้านวัณโรคในรูปของยาเม็ดแบนชนิดที่แตกตัว อย่างรวดเร็วซึ่งประกอบรวมด้วยแกรนูลของไอโซไนอาซิดและแกรนูลของ ไรฟาเพนทีน และกระบวนการเตรียมของมัน